← FDA Drug Approvals (Drugs@FDA)
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2020-12-17
Drug application
- FDA Application #
ANDA203433- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
- Generic name
- FLUTICASONE PROPIONATE AND SALMETEROL
- Active ingredients
- FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
- Dosage form
- POWDER
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- HIKMA
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- First approval
- 2020-12-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown